Watch: In the midst of an opioid epidemic, drug testing is exploding
Citing the high risk of addiction when prescribing opioids, physicians are requiring drug tests in record numbers. The testing market has since exploded to $8.5 billion annually in just a few short years. Now patients who aren’t addicted are getting saddled with surprise $15,000+ bills. The labs responsible are coming under scrutiny for the suspect…
This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.
Get featured
Want MarketScale to feature Healthcare?
Book a 15-minute demo and we'll map your Healthcare expertise to the content buyers are searching for.
Citing the high risk of addiction when prescribing opioids, physicians are requiring drug tests in record numbers. The testing market has since exploded to $8.5 billion annually in just a few short years. Now patients who aren’t addicted are getting saddled with surprise $15,000+ bills. The labs responsible are coming under scrutiny for the suspect practice, though action has yet to be taken.
Your experts belong here
Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.